TERN logo

Terns Pharmaceuticals (TERN)

Profile

Full Name

Terns Pharmaceuticals, Inc.

Ticker Symbol

TERN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 5, 2021

Indexes

Not included

Website

http://www.ternspharma.com

Employees

59

Key Details

Price

$2.24(-6.67%)

Market cap

$195.55M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.12(+11.81% YoY)

PE ratio

-

Next earnings date

May 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.24
TERN price is $2.24

30-Day Relative Volume

0.83
TERN 30-day relative volume is 0.83

Price Performance

Price Most recent change

-6.67%
TERN price was down -6.67% on Apr 16, 2025

Price YTD change

-59.57%
TERN price is down -59.57% since January 1st

Price 1-year change

-50.66%
TERN price is down -50.66% year-on-year

Price 3-year change

-12.84%
TERN price is down -12.84% over the past 3 years

Price Range

Price All-time high

$28.36
TERN price is currently -92.10% below its historical high of $28.36

Price 3-year low

$1.45
TERN price is currently +54.48% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$195.55M
TERN market capitalization is $195.55 million

Market cap 3-year change

+201.11%
TERN market capitalization is up +201.11% over the past 3 years

Market cap All-time high

$865.47M
TERN market capitalization is currently -77.41% below its historical high of $865.47 million

Market cap sector rank

57.65%
TERN market capitalization is higher than 57.65% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+35.03%
TERN shares outstanding is up +35.03% year-on-year

Shares Outstanding 3-Year Change

+245.47%
TERN shares outstanding is up +245.47% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.36
TERN beta is 1.36

200-day SMA

$6.16
TERN price is currently -63.64% below its 200-day simple moving average

50-day SMA

$3.33
TERN price is currently -32.82% below its 50-day simple moving average

RSI

35.57
TERN 14-day relative strength index is 35.57

Volume

0.83
TERN 30-day relative volume is 0.83

ATR

$0.23
TERN average true range is $0.23

10-day Historical Volatility

116.06%
TERN 10-day historical volatility is 116.06%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
TERN annual revenue value is unknown

Revenue Analysts estimate

-
TERN annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
TERN annual revenue 1-year change is unknown

Revenue Sector rank

-
TERN annual revenue is unknown

EPS

EPS

-$1.12
TERN annual earnings per share is -$1.12

EPS Analysts estimate

-$1.20
TERN annual earnings per share is currently -6.37% lower than the consensus analysts' forecast

EPS 1-year change

+11.81%
TERN annual earnings per share is up +11.81% year-on-year

EPS Sector rank

54.13%
TERN annual earnings per share is higher than 54.13% of companies in Healthcare sector

Profit

Gross profit

-
TERN annual gross profit value is unknown

Gross margin

-
TERN annual gross profit margin value is unknown

Operating profit

-$101.87M
TERN annual operating income is -$101.87 million

Operating margin

-
TERN annual operating profit margin value is unknown

Net income

-$88.85M
TERN annual net profit is -$88.85 million

Net margin

-
TERN annual net profit margin value is unknown

Expenses

Total expenses

$101.87M
TERN annual total expenses is $101.87 million

Operating expenses

$101.87M
TERN annual total operating expenses is $101.87 million

Cost of goods sold

-
TERN annual cost of goods sold value is unknown

Selling, general & administrative expenses

$31.76M
TERN annual SGA is $31.76 million

Depreciation and amortization

$896.00K
TERN annual depreciation & amortization is $896.00 thousand

Interest expense

-
TERN annual interest expense value is unknown

Income tax

$260.00K
TERN annual income tax is $260.00 thousand

EBIT & EBITDA

EBIT

-$101.87M
TERN annual earnings before interest & taxes is -$101.87 million

EBITDA

-$100.97M
TERN annual EBITDA is -$100.97 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$363.93M
TERN annual total assets is $363.93 million

Non current assets

$1.82M
TERN annual long term assets is $1.82 million

Current assets

$362.11M
TERN annual total current assets is $362.11 million

Cash and cash equivalents

$161.44M
TERN annual cash & cash equivalents is $161.44 million

Accounts receivable

-
TERN annual accounts receivable value is unknown

Inventory

-
TERN annual inventory value is unknown

Liabilities

Total liabilities

$18.06M
TERN annual total liabilities is $18.06 million

Long term liabilities

$2.41M
TERN annual total long term liabilities is $2.41 million

Current liabilities

$15.65M
TERN annual total current liabilities is $15.65 million

Accounts payable

$2.15M
TERN annual accounts payable is $2.15 million

Debt

Total debt

$1.35M
TERN annual total debt is $1.35 million

Total debt 1-year change

+123.38%
TERN annual total debt is up +123.38% year-on-year

Long term debt

$919.00K
TERN annual long term debt is $919.00 thousand

Short term debt

$428.00K
TERN annual short term debt is $428.00 thousand

Equity & Capital

Shareholders equity

$345.87M
TERN annual stockholders equity is $345.87 million

Book value

$345.87M
TERN annual book value is $345.87 million

Retained earnings

-$421.48M
TERN annual retained earnings is -$421.48 million

Working capital

$346.46M
TERN annual working capital is $346.46 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$70.02M
TERN annual cash flow from operations is -$70.02 million

Cash from operations 1-year change

-3.9%
TERN annual cash flow from operations is down -3.9% year-on-year

Cash from investing

-$12.41M
TERN annual cash flow from investing activities is -$12.41 million

Cash from investing 1-year change

+67.33%
TERN annual cash flow from investing activities is up +67.33% year-on-year

Cash from financing

$164.00M
TERN annual cash flow from financing activities is $164.00 million

Cash from financing 1-year change

+290.92%
TERN annual cash flow from financing activities is up +290.92% year-on-year

CAPEX

CAPEX

-
TERN annual capital expenditures value is unknown

CAPEX 1-year change

-
TERN annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$70.06M
TERN annual free cash flow is -$70.06 million

Free cash flow 1-year change

-3.88%
TERN annual free cash flow is down -3.88% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
TERN annual gross profit margin value is unknown

Operating margin

-
TERN annual operating profit margin value is unknown

Net margin

-
TERN annual net profit margin value is unknown

ROA & ROE

ROA

-24.41%
TERN annual return on assets is -24.41%

ROE

-25.69%
TERN annual return on equity is -25.69%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
TERN price to earnings ratio value is unknown

PE ratio Sector rank

-
TERN price to earnings ratio is unknown

PB Ratio

PB ratio

0.57
TERN price to book ratio is 0.57

PB ratio Sector rank

32.29%
TERN price to book ratio is higher than 32.29% of companies in Healthcare sector

PS Ratio

PS ratio

-
TERN price to sales ratio value is unknown

PS ratio Sector rank

-
TERN price to sales ratio is unknown

Enterprise value

Enterprise value

$35.45M
TERN enterprise value is $35.45 million

Enterprise value Sector rank

37.24%
TERN enterprise value is higher than 37.24% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.35
TERN EV/EBITDA is -0.35

EV/EBITDA Sector rank

54.52%
TERN EV/EBITDA is higher than 54.52% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

23.14
TERN annual current ratio is 23.14

Quick ratio

-
TERN annual quick ratio value is unknown

Leverage

Debt to equity

0.00
TERN annual debt to equity ratio is 0.00

Interest coverage ratio

-
TERN annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
TERN piotroski f-score value is unknown

Altman Z-Score

-
TERN altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Feb 28, 25 William Blair
Market Perform
Dec 4, 24 Oppenheimer
Outperform
Dec 4, 24 JMP Securities
Market Outperform
Dec 4, 24 HC Wainwright & Co.
Neutral
Nov 13, 24 HC Wainwright & Co.
Neutral
Oct 31, 24 Oppenheimer
Outperform
Sep 16, 24 BMO Capital
Outperform
Sep 10, 24 JMP Securities
Market Outperform
Sep 3, 24 JMP Securities
Market Outperform
Aug 6, 24 BMO Capital
Outperform

Institutional Ownership

Similar stocks

SLDB logo
Solid Biosciences (SLDB)
ELMD logo
Electromed (ELMD)
AMRN logo
Amarin (AMRN)
OM logo
Outset Medical (OM)
FHTX logo
Foghorn Therapeutics (FHTX)
DSGN logo
Design Therapeutics (DSGN)
PDEX logo
Pro-Dex (PDEX)
Performant Healthcare (PHLT)
ANIK logo
Anika Therapeutics (ANIK)
  • What is the ticker symbol for Terns Pharmaceuticals?
  • Does Terns Pharmaceuticals pay dividends?
  • What sector is Terns Pharmaceuticals in?
  • What industry is Terns Pharmaceuticals in?
  • What country is Terns Pharmaceuticals based in?
  • When did Terns Pharmaceuticals go public?
  • Is Terns Pharmaceuticals in the S&P 500?
  • Is Terns Pharmaceuticals in the NASDAQ 100?
  • Is Terns Pharmaceuticals in the Dow Jones?
  • When was Terns Pharmaceuticals's last earnings report?
  • When does Terns Pharmaceuticals report earnings?
  • Should I buy Terns Pharmaceuticals stock now?

What is the ticker symbol for Terns Pharmaceuticals?

The ticker symbol for Terns Pharmaceuticals is NASDAQ:TERN

Does Terns Pharmaceuticals pay dividends?

No, Terns Pharmaceuticals does not pay dividends

What sector is Terns Pharmaceuticals in?

Terns Pharmaceuticals is in the Healthcare sector

What industry is Terns Pharmaceuticals in?

Terns Pharmaceuticals is in the Biotechnology industry

What country is Terns Pharmaceuticals based in?

Terns Pharmaceuticals is headquartered in United States

When did Terns Pharmaceuticals go public?

Terns Pharmaceuticals's initial public offering (IPO) was on February 5, 2021

Is Terns Pharmaceuticals in the S&P 500?

No, Terns Pharmaceuticals is not included in the S&P 500 index

Is Terns Pharmaceuticals in the NASDAQ 100?

No, Terns Pharmaceuticals is not included in the NASDAQ 100 index

Is Terns Pharmaceuticals in the Dow Jones?

No, Terns Pharmaceuticals is not included in the Dow Jones index

When was Terns Pharmaceuticals's last earnings report?

Terns Pharmaceuticals's most recent earnings report was on Mar 20, 2025

When does Terns Pharmaceuticals report earnings?

The next expected earnings date for Terns Pharmaceuticals is May 13, 2025

Should I buy Terns Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page